Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

The Boston Globe featured an Eskenazi Health program led by Regenstrief Research Scientist Malaz Boustani, M.D., in an article describing the launch of a new Massachusetts General Hospital program to support primary care physicians in caring for older patients living with dementia.

The program is similar to the one at Sandra Eskenazi Center for Brain Care Innovation, led by Dr. Boustani, who is also the director for the Center for Health Innovation and Implementation Science.

The collaborative dementia care program was started by Eskenazi more than a decade ago. The system trains and employs community health workers who meet with families of people with dementia. The workers help those families address difficulties, actively work to reduce stress and keep track of how the families are functioning.

Massachusetts General Hospital is launching a pilot program where a dementia care team will be embedded in primary care practices at the hospital. The specialists and social workers can help those doctors when they suspect one of their patients may have dementia.

A recent survey by the Alzheimer’s Association® found that less than half of physicians reported assessing their older patients for cognitive impairment.

“I feel their pain. The primary care doctors, they don’t have the resources, they don’t have the time,” Dr. Boustani told the Globe. He believes that programs like the one at Eskenazi can lead to better health and quality of life for people with dementia and their families.

Dr. Boustani also is a professor at Indiana University School of Medicine and the director for the Center for Health Innovation and Implementation Science.

Read the entire Boston Globe Article here.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
jorerick@regenstrief.org
(317) 274-9062

Related News

May 12, 2021 • News
Eliminating bias from healthcare AI critical to improve health equity
Algorithms must be tested and continually monitored to assess impact of bias  Artificial intelligence (AI)-driven healthcare has the potential to transform medical decision-making and treatment, but these algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients.   In a JAMA Network Open Invited Commentary, Regenstrief Institute President and Chief Executive Officer and Indiana University…
Continue Reading >
May 07, 2021 • News
Regenstrief researcher wins American Board of Internal Medicine Foundation award for paper
Regenstrief Institute Research Scientist Richard Frankel, PhD, won the 2020 John A. Benson Jr., M.D., Professionalism Article Prize from the American Board of Internal Medicine (ABIM) Foundation. The award recognizes peer-reviewed journal articles that document the impact of medical professionalism on improving healthcare.   Dr. Frankel was the senior author on the paper “If your feelings were hurt, I’m sorry…” How…
Continue Reading >